Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.11 CNY
4.06 B CNY
75.17 B CNY
534.90 M
About GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED
Sector
CEO
Hong Li
Headquarters
Guangzhou
Website
Founded
1997
ISIN
CNE000001733
FIGI
BBG000FM3Z94
Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. engages in the manufacture, wholesale, retail, import, and export of pharmaceutical products, medical apparatus, and Chinese medicine. It operates in the following segments: Great Southern Traditional Chinese Medicine (TCM), Great Health, Great Commerce, and Other. The Great Southern TCM segment provides research, development, manufacturing, and sales for Chinese and Western medicine. The Great Health segment refers to the research, development, manufacturing, and sales for the products of Great Health. The Great Commerce segment relates to the wholesale, retail, import, and export for Western medicine, Chinese medicine, and medical apparatus and instruments. The Other segment is involved in other manufacturing and distributing traditional Chinese medicines activities. The company was founded on September 1, 1997 and is headquartered in Guangzhou, China.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 600332 is 29.07 CNY — it has increased by 0.17% in the past 24 hours. Watch GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stocks are traded under the ticker 600332.
600332 stock has risen by 0.70% compared to the previous week, the month change is a 3.06% rise, over the last year GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED has showed a 2.83% increase.
We've gathered analysts' opinions on GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED future price: according to them, 600332 price has a max estimate of 36.10 CNY and a min estimate of 18.80 CNY. Watch 600332 chart and read a more detailed GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock forecast: see what analysts think of GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED and suggest that you do with its stocks.
600332 reached its all-time high on Jun 3, 2015 with the price of 48.46 CNY, and its all-time low was 4.41 CNY and was reached on Nov 7, 2008. View more price dynamics on 600332 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
600332 stock is 1.04% volatile and has beta coefficient of 1.05. Track GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock price on the chart and check out the list of the most volatile stocks — is GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED there?
Today GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED has the market capitalization of 46.99 B, it has increased by 0.37% over the last week.
Yes, you can track GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financials in yearly and quarterly reports right on TradingView.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED is going to release the next earnings report on Mar 17, 2025. Keep track of upcoming events with our Earnings Calendar.
600332 earnings for the last quarter are 0.37 CNY per share, whereas the estimation was 0.45 CNY resulting in a −17.78% surprise. The estimated earnings for the next quarter are 0.30 CNY per share. See more details about GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED earnings.
600332 net income for the last quarter is 609.41 M CNY, while the quarter before that showed 591.45 M CNY of net income which accounts for 3.04% change. Track more GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED financial stats to get the full picture.
GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED dividend yield was 2.60% in 2023, and payout ratio reached 29.85%. The year before the numbers were 2.35% and 28.64% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 25, 2024, the company has 28.05 K employees. See our rating of the largest employees — is GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED on this list?
Like other stocks, 600332 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED stock shows the sell signal. See more of GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.